 |
26 Nov 2024 – Two projects come to an end |
|
|
|
Smash Childhood Cancer and Help Stop TB concluded their phase with the WCG and are providing us with a final update. |
|
|
Tags:
Project Update
|
|
|
|
31 Oct 2024 – ARP restart update |
|
|
|
The ARP project will be restarting by Monday November 4, following the technical pause it entered in December 2022. |
|
|
Tags:
Project Update
|
|
|
|
10 Jul 2024 – Research Update from the MCM team (July 2024) |
|
|
|
We continue to characterise lung cancer biomarkers identified in the MCM1 project. This update focuses on ASTN2, a protein involved in neuronal migration. It is expressed across several tissue types, and has been implicated in various cancers. |
|
|
Tags:
Project Update
|
|
|
|
13 May 2024 – Research update from the MCM team (May 2024) |
|
|
|
We continue to characterise lung cancer biomarkers identified in the MCM1 project. This update focuses on KLF5, a well-studied gene that has been implicated in several cancer types. KLF5 is a transcription factor, which is expressed across numerous organs and tissues. |
|
|
Tags:
Project Update
|
|
|
|
25 Apr 2024 – ARP restart update |
|
|
|
The ARP team is preparing to restart after the project was put on pause in December 2022. This article outlines the steps that we are taking in order to restart this project. |
|
|
Tags:
Project Update
|
|
|
|
14 Mar 2024 – Research update from the MCM team (March 2024) |
|
|
|
We continue to characterise lung cancer biomarkers identified in the MCM1 project. This update focuses on HSD17B11, a gene associated with lung cancer survival. HSD17B11 is a protein coding gene, relatively ubiquitously expressed across organs and tissues. It is a short-chain alcohol dehydrogenase that metabolises secondary alcohols and ketones. |
|
|
Tags:
Project Update
|
|
|
|
|
|
|
|
16 Jan 2024 – Research update from the MCM team (January 2024) |
|
|
|
We continue our work on characterizing lung cancer biomarkers identified in the MCM1 project. This update focuses on PCSK5, a gene associated with lung cancer survival and which shows differential expression across various cancer types. |
|
|
Tags:
Project Update
|
|
|
|
27 Nov 2023 – Research update from the MCM team (November 2023) |
|
|
|
We continue our work on characterizing lung cancer biomarkers identified in the MCM1 project. This update focuses on IL13RA1, a gene associated with lung cancer survival and differentially expressed across multiple cancer types compared to normal tissues. |
|
|
Tags:
Project Update
|
|
|
